Targeting microRNAs for the treatment of liver cancer

Details for Australian Patent Application No. 2008318778 (hide)

Owner Regulus Therapeutics Inc. Rosetta Genomics Ltd.

Inventors Esau, Christine; Chajut, Ayelet; Yerushalmi, Noga; Bennett, C. Frank; Marcusson, Eric G.

Agent Spruson & Ferguson

Pub. Number AU-A-2008318778

PCT Pub. Number WO2009/058907

Priority 60/983,231 29.10.07 US

Filing date 29 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058907 Priority application(s): WO2009/058907

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008318784-Test strips and system for measuring analyte levels in a fluid sample

2008318777-Control arrangement and method for communicating paging messages in a wireless communication system